Breakthrough immunotherapy for Chronic Hepatitis B virus infection – Markets Insider
|
Breakthrough immunotherapy for Chronic Hepatitis B virus infection
Markets Insider Lion TCR is a clinical-stage T cell immunotherapy company specialized on the development and commercialisation of its proprietary technologic and T cell products against viral-related cancers. In Asia, out of every 5 cancer, 1 is caused by viral infection. |
